Log in

While You Were Socially Distancing – Washington Has Been Busy: Summary of the Top Rules Impacting Providers and Payors for 2021

  • October 21, 2020
  • 8:00 AM - 9:00 AM
  • via Zoom


Registration is closed

While you were occupied with COVID response, the federal agencies responsible for regulating health care providers and payors have been busy. Erin Eiselein and Anna-Liisa Mullis will provide an update on new or revised rules impacting providers and payors for 2021.

Highlights include:

  • The new interoperability rules (data access/CURES Act).
  • Changes to Part 2 regulations and to the Part 2 authorizing law in the CARES Act.
  • Litigation over the changes to the Section 1557 definition under the ACA (including removal of health care protections for transgender individuals).
  • Executive orders on drug pricing.
  • Status of court challenge to hospital price transparency rule.
  • The D.C. Circuit ruling on the site of service changes.
  • The delay on final Stark regulations until August 2021.

A seasoned litigator, Erin Eiselein counsels clients on a wide variety of disputes and regulatory issues facing the health care industry. Representing health care practitioners, community health organizations, medical device companies and hospital systems, Erin has a unique understanding of both the law and the constantly evolving regulatory, political and business issues impacting the health care industry. 

Anna-Liisa Mullis has a background representing health care organizations and professionals in a variety of matters before trial and appellate courts, as well as in private arbitration. Her work has included both defending and prosecuting a multitude of complex matters, including disputes involving hospital-provider contracting, hospital-vendor contracting, hospital-physician joint ventures, physician-owned entities and provider-payor disputes as well as antitrust disputes in the healthcare sector. Along with her litigation practice, Anna-Liisa also works closely with clients on analyzing and advising on a wide variety of fraud and abuse, patient privacy, data and innovation matters. 

Powered by Wild Apricot Membership Software